{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:12:22Z","timestamp":1793362342379,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Graduate Nursing Education Teaching Team","award":["193YST011"],"award-info":[{"award-number":["193YST011"]}]},{"DOI":"10.13039\/501100004761","name":"the Natural Science Foundation of Hunan Province, China","doi-asserted-by":"crossref","award":["2023JJ50137"],"award-info":[{"award-number":["2023JJ50137"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sarcopenia represents a considerable public health issue and is associated with increased mortality and complication rates in patients with type 2 diabetes mellitus (T2DM). Existing evidence regarding adverse outcomes in patients with T2DM and sarcopenia is currently scattered and limited, and comprehensive evidence is lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive search of Embase, PubMed, Scopus, and Web of Science was conducted to identify relevant studies that assessed the impact of sarcopenia on mortality, cardiovascular disease (CVD), and complications in individuals with T2DM. The quality of the included studies was evaluated using the Newcastle-Ottawa Scale and the Joanna Briggs Institute Critical Appraisal tool. The pooled hazard ratios and odds ratios, along with their corresponding 95% confidence intervals for mortality, CVD, and complication estimates, were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifteen studies were included in the meta-analysis. The overall risk of bias across the studies was low. Patients with T2DM and sarcopenia had a considerably elevated risk of mortality, with a pooled hazard ratio of 1.72 (95% CI\u2009=\u20091.28\u20132.32). Similarly, sarcopenia was associated with an increased hazard ratio for CVD of 1.94 (95% CI\u2009=\u20091.67\u20132.25). Furthermore, sarcopenia was associated with an elevated risk of developing diabetic complications, as evidenced by a hazard ratio of 1.12 (95% CI\u2009=\u20091.09\u20131.15) and an odds ratio of 2.49 (95% CI\u2009=\u20091.53\u20134.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Sarcopenia is predictive of adverse outcomes, including mortality, CVD, and diabetic complications, in patients with T2DM. Our findings underscore the clinical imperative for integrating sarcopenia assessment into routine T2DM management to facilitate early risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13098-025-01998-w","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:30:32Z","timestamp":1762345832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Sarcopenia as a predictor of negative health outcomes in patients with type 2 diabetes mellitus: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1958-1054","authenticated-orcid":false,"given":"Hao","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3462-1309","authenticated-orcid":false,"given":"Yaqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyuan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6143-5143","authenticated-orcid":false,"given":"Li","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"1998_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"966","key":"1998_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/pmj.2005.039032","volume":"82","author":"C Daousi","year":"2006","unstructured":"Daousi C, Casson IF, Gill GV, et al. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgrad Med J. 2006;82(966):280\u20134.","journal-title":"Postgrad Med J"},{"issue":"12","key":"1998_CR3","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.2337\/dc12-1801","volume":"35","author":"MS Kirkman","year":"2012","unstructured":"Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care. 2012;35(12):2650\u201364.","journal-title":"Diabetes Care"},{"issue":"9733","key":"1998_CR4","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Emerging Risk Factors Collaboration, Sarwar N, Gao P, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies[J]. Lancet (London England). 2010;375(9733):2215\u201322.","journal-title":"Lancet (London England)"},{"issue":"2","key":"1998_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70581","volume":"14","author":"A Ramandi","year":"2025","unstructured":"Ramandi A, George J, Behnoush AH, et al. The association between serum gamma-glutamyl transferase and gastrointestinal cancer risk: a systematic review and meta-analysis. Cancer Med. 2025;14(2):e70581.","journal-title":"Cancer Med"},{"issue":"3","key":"1998_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"LK Chen","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and Treatment[J]. J Am Med Dir Assoc. 2020;21(3):300\u2013e3072.","journal-title":"J Am Med Dir Assoc"},{"issue":"7","key":"1998_CR7","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/jgs.16372","volume":"68","author":"S Bhasin","year":"2020","unstructured":"Bhasin S, Travison TG, Manini TM, et al. Sarcopenia definition: the position statements of the sarcopenia definition and outcomes consortium. J Am Geriatr Soc. 2020;68(7):1410\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"1998_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/ageing\/afz046","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Agng. 2019;48(4):601.","journal-title":"Age Agng"},{"issue":"4","key":"1998_CR9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older People[J]. Age Agng. 2010;39(4):412\u201323.","journal-title":"Age Agng"},{"key":"1998_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40200-017-0302-x","volume":"16","author":"G Shafiee","year":"2017","unstructured":"Shafiee G, Keshtkar A, Soltani A, et al. Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord. 2017;16:21.","journal-title":"J Diabetes Metab Disord"},{"issue":"10","key":"1998_CR11","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s12603-011-0366-0","volume":"15","author":"AM Abbatecola","year":"2011","unstructured":"Abbatecola AM, Paolisso G, Fattoretti P, et al. Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction. J Nutr Health Aging. 2011;15(10):890\u20135.","journal-title":"J Nutr Health Aging"},{"issue":"4","key":"1998_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4235\/agmr.19.0038","volume":"23","author":"HC Jang","year":"2019","unstructured":"Jang HC. Diabetes and muscle dysfunction in older adults. Annals of Geriatric Medicine and Research. 2019;23(4):160\u20134.","journal-title":"Annals of Geriatric Medicine and Research"},{"issue":"7","key":"1998_CR13","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1253\/circj.CJ-16-0506","volume":"80","author":"F Yoshihara","year":"2016","unstructured":"Yoshihara F. Systemic inflammation is a key factor for mortality risk stratification in chronic kidney disease patients with coronary artery calcification. Circ J. 2016;80(7):1537\u20138.","journal-title":"Circ J"},{"issue":"1","key":"1998_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-024-05012-2","volume":"24","author":"B Guo","year":"2024","unstructured":"Guo B, Liu X, Si Q, et al. Associations of CBC-derived inflammatory indicators with sarcopenia and mortality in adults: evidence from Nhanes 1999 \u223c 2006. BMC Geriatr. 2024;24(1):432.","journal-title":"BMC Geriatr"},{"issue":"2","key":"1998_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/wvn.12147","volume":"13","author":"SF Chang","year":"2016","unstructured":"Chang SF, Lin PL. Systematic literature review and meta-analysis of the association of sarcopenia with mortality. Worldviews on Evidence-Based Nursing. 2016;13(2):153\u201362.","journal-title":"Worldviews on Evidence-Based Nursing"},{"issue":"6","key":"1998_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s41999-019-00233-w","volume":"10","author":"N Veronese","year":"2019","unstructured":"Veronese N, Demurtas J, Soysal P, et al. Sarcopenia and health-related outcomes: an umbrella review of observational studies. Eur Geriatr Med. 2019;10(6):853\u201362.","journal-title":"Eur Geriatr Med"},{"issue":"6","key":"1998_CR17","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/jcsm.12825","volume":"12","author":"KYK Cheng","year":"2021","unstructured":"Cheng KYK, Chow SKH, Hung VW, Y, et al. Diagnosis of sarcopenia by evaluating skeletal muscle mass by adjusted bioimpedance analysis validated with dual-energy X-ray absorptiometry[J]. J Cachexia Sarcopenia Muscle. 2021;12(6):2163\u201373.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1998_CR18","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/jdi.13752","volume":"13","author":"CY Wen","year":"2022","unstructured":"Wen CY, Lien AS, Jiang YD. Sarcopenia in elderly diabetes. J Diabetes Investig. 2022;13:944\u20136.","journal-title":"J Diabetes Investig"},{"issue":"9","key":"1998_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2023.102835","volume":"17","author":"A Marcotte-Ch\u00e9nard","year":"2023","unstructured":"Marcotte-Ch\u00e9nard A, Oliveira B, Little JP, et al. Sarcopenia and type 2 diabetes: pathophysiology and potential therapeutic lifestyle interventions. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2023;17(9):102835.","journal-title":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews"},{"issue":"19","key":"1998_CR20","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.3390\/nu15194149","volume":"15","author":"C Salom Vendrell","year":"2023","unstructured":"Salom Vendrell C, Garc\u00eda Tercero E, Moro Hern\u00e1ndez JB, et al. Sarcopenia as a Little-Recognized comorbidity of type II diabetes mellitus: A review of the diagnosis and Treatment[J]. Nutrients. 2023;15(19):4149.","journal-title":"Nutrients"},{"issue":"7","key":"1998_CR21","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/jgs.16517","volume":"68","author":"PM Cawthon","year":"2020","unstructured":"Cawthon PM, Manini T, Patel SM, et al. Putative cut-points in sarcopenia components and incident adverse health outcomes: an SDOC analysis. J Am Geriatr Soc. 2020;68(7):1429\u201337.","journal-title":"J Am Geriatr Soc"},{"key":"1998_CR22","first-page":"e13187","volume-title":"Falls, fractures, and areal bone mineral density in older adults with sarcopenic obesity: A systematic review and meta-analysis[J]","author":"A Gandham","year":"2021","unstructured":"Gandham A, Mesinovic J, Jansons P, et al. Falls, fractures, and areal bone mineral density in older adults with sarcopenic obesity: A systematic review and meta-analysis[J]. Volume 22. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity; 2021. p. e13187. 5."},{"issue":"3","key":"1998_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jcsm.12411","volume":"10","author":"SS,Y Yeung","year":"2019","unstructured":"Yeung SS Y, Reijnierse EM, Pham VK, et al. Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2019;10(3):485\u2013500.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"10","key":"1998_CR24","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration[J]. J Clin Epidemiol. 2009;62(10):e1\u201334.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"1998_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, Moola S, Lisy K, et al. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. International Journal of Evidence-Based Healthcare. 2015;13(3):147\u201353.","journal-title":"International Journal of Evidence-Based Healthcare"},{"issue":"9","key":"1998_CR26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the NewcastleOttawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"1998_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455\u201363.","journal-title":"Biometrics"},{"issue":"10","key":"1998_CR28","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1007\/s12603-022-1846-0","volume":"26","author":"KC Chai","year":"2022","unstructured":"Chai KC, Chen WM, Chen M, et al. Association between preexisting sarcopenia and stroke in patients with type 2 diabetes mellitus. J Nutr Health Aging. 2022;26(10):936\u201344.","journal-title":"J Nutr Health Aging"},{"key":"1998_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13464","author":"L Wei","year":"2024","unstructured":"Wei L, Zeng J, Fan M, et al. Associations between handgrip strength and skeletal muscle mass with all-cause mortality and cardiovascular mortality in people with type 2 diabetes: a prospective cohort study of the UK Biobank. J Diabetes. 2024;16(1):e13464. https:\/\/doi.org\/10.1111\/1753-0407.13464.","journal-title":"J Diabetes"},{"issue":"12","key":"1998_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/1753-0407.13216","volume":"13","author":"S Park","year":"2021","unstructured":"Park S, Kim SH, Shin JY. Combined association of skeletal muscle mass and grip strength with cardiovascular diseases in patients with type 2 diabetes. J Diabetes. 2021;13(12):1015\u201324.","journal-title":"J Diabetes"},{"issue":"9","key":"1998_CR31","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s40520-023-02473-0","volume":"35","author":"X Ye","year":"2023","unstructured":"Ye X, Chuan F, Li Y, et al. Comparing the prognostic value of the old and new sarcopenia criteria from the Asian working group on sarcopenia in older adults with type 2 diabetes: which set is more appropriate?[J]. Aging Clin Exp Res. 2023;35(9):1917\u201326.","journal-title":"Aging Clin Exp Res"},{"key":"1998_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154424","author":"JA Lin","year":"2022","unstructured":"Lin JA, Hou JD, Wu SY. Effect of sarcopenia on mortality in type 2 diabetes: a long-term follow-up propensity score-matched diabetes cohort study. J Clin Med. 2022;11(15):4424. https:\/\/doi.org\/10.3390\/jcm11154424.","journal-title":"J Clin Med"},{"key":"1998_CR33","doi-asserted-by":"crossref","unstructured":"Chung HS, Hwang SY, Choi JH, et al. Effects of low muscle mass on albuminuria and chronic kidney disease in patients with type 2 diabetes: the Korean sarcopenic obesity study (KSOS)[J]. Volume 73. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES; 2018. pp. 386\u201392. 3.","DOI":"10.1093\/gerona\/glx055"},{"issue":"2","key":"1998_CR34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/dom.15338","volume":"26","author":"J Boonpor","year":"2024","unstructured":"Boonpor J, Pell JP, Ho FK, et al. In people with type 2 diabetes, sarcopenia is associated with the incidence of cardiovascular disease: a prospective cohort study from the UK Biobank. Diabetes Obes Metab. 2024;26(2):524\u201331.","journal-title":"Diabetes Obes Metab"},{"key":"1998_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.111063","volume":"207","author":"MV Beretta","year":"2024","unstructured":"Beretta MV, de Paula TP, da Costa Rodrigues T, et al. Prolonged hospitalization and 1-year mortality are associated with sarcopenia and malnutrition in older patients with type 2 diabetes: a prospective cohort study. Diabetes Res Clin Pract. 2024;207:111063.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"1998_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad347","volume":"6","author":"M Sun","year":"2023","unstructured":"Sun M, Lu Z, Chen WM, et al. Sarcopenia and diabetes-induced dementia risk. Brain Commun. 2023;6(1):fcad347.","journal-title":"Brain Commun"},{"key":"1998_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.diabres.2016.06.023","volume":"118","author":"R Yang","year":"2016","unstructured":"Yang R, Zhang Y, Shen X, et al. Sarcopenia associated with renal function in the patients with type 2 diabetes. Diabetes Res Clin Pract. 2016;118:121\u20139.","journal-title":"Diabetes Res Clin Pract"},{"key":"1998_CR38","doi-asserted-by":"crossref","unstructured":"Huang CWM, Chen M et al. Sarcopenia is an independent risk factor for severe diabetic nephropathy in type 2 diabetes: A Long-Term Follow-Up propensity Score\u2013Matched diabetes cohort Study[J]. J Clin Med. 2022;11(11):2992.","DOI":"10.3390\/jcm11112992"},{"key":"1998_CR39","doi-asserted-by":"crossref","unstructured":"Takahashi F, Hashimoto Y, Kaji A et al. Sarcopenia is associated with a risk of mortality in people with type 2 diabetes Mellitus[J]. Front Endocrinol. 2021;12:783363.","DOI":"10.3389\/fendo.2021.783363"},{"issue":"1","key":"1998_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-018-0700-5","volume":"17","author":"T Fukuda","year":"2018","unstructured":"Fukuda T, Bouchi R, Takeuchi T, et al. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study. Cardiovasc Diabetol. 2018;17(1):55.","journal-title":"Cardiovasc Diabetol"},{"key":"1998_CR41","doi-asserted-by":"crossref","unstructured":"Chuan F, Chen S, Ye X et al. Sarcopenic obesity predicts negative health outcomes among older patients with type 2 diabetes: The Agng and Body Composition of Diabetes (ABCD) cohort study[J]. Clinical Nutrition (Edinburgh, Scotland), 2022, 41(12): 2740\u20132748.","DOI":"10.1016\/j.clnu.2022.10.023"},{"issue":"6","key":"1998_CR42","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/jdi.12636","volume":"8","author":"R Bouchi","year":"2017","unstructured":"Bouchi R, Fukuda T, Takeuchi T, et al. Sarcopenia is associated with incident albuminuria in patients with type 2 diabetes: a retrospective observational study. J Diabetes Investig. 2017;8(6):783\u20137.","journal-title":"J Diabetes Investig"},{"key":"1998_CR43","doi-asserted-by":"crossref","unstructured":"Ai Y, Xu R, Liu L. The prevalence and sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis[J]. Volume 13. Diabetology & Metabolic Syndrome; 2021. p. 93. 1.","DOI":"10.1186\/s13098-021-00707-7"},{"issue":"5","key":"1998_CR44","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1210\/clinem\/dgab884","volume":"107","author":"L Feng","year":"2022","unstructured":"Feng L, Gao Q, Hu K, et al. Prevalence and risk factors of sarcopenia in patients with diabetes: a meta-analysis. J Clin Endocrinol Metab. 2022;107(5):1470\u201383.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1998_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/nu13010183","volume":"13","author":"A Izzo","year":"2021","unstructured":"Izzo A, Massimino E, Riccardi G, et al. A narrative review on sarcopenia in type 2 diabetes mellitus: prevalence and associated factors. Nutrients. 2021;13(1):183.","journal-title":"Nutrients"},{"issue":"5","key":"1998_CR46","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00223-020-00742-y","volume":"107","author":"P Anagnostis","year":"2020","unstructured":"Anagnostis P, Gkekas NK, Achilla C, et al. Type 2 diabetes mellitus is associated with increased risk of sarcopenia: a systematic review and meta-analysis. Calcif Tissue Int. 2020;107(5):453\u201363.","journal-title":"Calcif Tissue Int"},{"key":"1998_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afy106","author":"AJ Mayhew","year":"2018","unstructured":"Mayhew AJ, Amog K, Phillips SM, et al. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing. 2019;48(1):48\u201356. https:\/\/doi.org\/10.1093\/ageing\/afy106.","journal-title":"Age Ageing"},{"issue":"1","key":"1998_CR48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jamda.2018.06.004","volume":"20","author":"M Locquet","year":"2019","unstructured":"Locquet M, Beaudart C, Hajaoui M, et al. Three-Year adverse health consequences of sarcopenia in Community-Dwelling older adults according to 5 diagnosis Definitions.[J]. J Am Med Dir Assoc. 2019;20(1):43\u2013462.","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"1998_CR49","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","volume":"29","author":"M Muscaritoli","year":"2010","unstructured":"Muscaritoli M, Anker SD, Argil\u00e9s J, et al. Consensus definition of sarcopenia, cachexia and cachexia: joint document elaborated by special interest groups (SIG) cachexia-anorexia in chronic wasting diseases and nutrition in geriatrics[J]. Clin Nutr. 2010;29(2):154\u20139.","journal-title":"Clin Nutr"},{"issue":"5","key":"1998_CR50","first-page":"547","volume":"69","author":"SA Studenski","year":"2014","unstructured":"Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. The Journals of Gerontology: Series A. 2014;69(5):547\u201358.","journal-title":"The Journals of Gerontology: Series A"},{"key":"1998_CR51","doi-asserted-by":"crossref","unstructured":"Heymsfield SB, Adamek M, Gonzalez MC, Jia G, Thomas DM. Assessing skeletal muscle mass: historical overview and state of the art. J Cachexia Sarcopenia Muscle. 2014;5(1):9\u201318.","DOI":"10.1007\/s13539-014-0130-5"},{"issue":"4","key":"1998_CR52","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000517099","volume":"68","author":"J Xu","year":"2022","unstructured":"Xu J, Wan CS, Ktoris K, et al. Sarcopenia is associated with mortality in adults: a systematic review and meta-analysis. Gerontology. 2022;68(4):361\u201376.","journal-title":"Gerontology"},{"issue":"2","key":"1998_CR53","first-page":"300","volume":"49","author":"F Petermann-Rocha","year":"2020","unstructured":"Petermann-Rocha F, Chen M, Gray SR, et al. New versus old guidelines for sarcopenia classification: what is the impact on prevalence and health outcomes?[J]. Age Agng. 2020;49(2):300\u20134.","journal-title":"Age Agng"},{"issue":"2","key":"1998_CR54","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12603-020-1474-5","volume":"25","author":"P Huang","year":"2021","unstructured":"Huang P, Luo K, Xu J, et al. Sarcopenia as a risk factor for future hip fracture: a meta-analysis of prospective cohort studies. J Nutr Health Aging. 2021;25(2):183\u20138.","journal-title":"J Nutr Health Aging"},{"key":"1998_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.maturitas.2017.04.007","volume":"103","author":"P Liu","year":"2017","unstructured":"Liu P, Hao Q, Hai S, et al. Sarcopenia as a predictor of all-cause mortality among community-dwelling older people: a systematic review and meta-analysis. Maturitas. 2017;103:16\u201322.","journal-title":"Maturitas"},{"issue":"11","key":"1998_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-021252","volume":"8","author":"X Zhang","year":"2018","unstructured":"Zhang X, Wang C, Dou Q, et al. Sarcopenia as a predictor of all-cause mortality among older nursing home residents: a systematic review and meta-analysis. BMJ Open. 2018;8(11):e021252.","journal-title":"BMJ Open"},{"issue":"5","key":"1998_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8050712","volume":"8","author":"DO Kang","year":"2019","unstructured":"Kang DO, Park SY, Choi BG, et al. Prognostic impact of low skeletal muscle mass on major adverse cardiovascular events in coronary artery disease: a propensity score-matched analysis of a single center all-comer cohort. J Clin Med. 2019;8(5):712.","journal-title":"J Clin Med"},{"issue":"10191","key":"1998_CR58","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636\u201346.","journal-title":"Lancet"},{"issue":"5","key":"1998_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010805","volume":"5","author":"P Srikanthan","year":"2010","unstructured":"Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS ONE. 2010;5(5):e10805.","journal-title":"PLoS ONE"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01998-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01998-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01998-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T13:07:53Z","timestamp":1762348073000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01998-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1998"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01998-w","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"416"}}